IFNA1 and rheumatoid arthritis: Moreover, it has been recently suggested that the detection of an IFN signature in peripheral blood is associated with poor response to both B-cell depleting therapy (rituximab) and anti-IL-6R treatment (tocilizumab) in rheumatoid arthritis patients [33, 34].